C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/54 (2006.01) A61K 38/43 (2006.01) A61K 38/45 (2006.01) A61P 3/10 (2006.01) C12N 1/21 (2006.01) C12N 9/12 (2006.01) C12Q 1/68 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2473566
The invention relates to isolated nucleic acid molecules and to host cells comprising such nucleic acid molecules. Moreover, the invention relates to a polypeptide having PIM-3, activity and having a definite amino acid sequence, as well as to the use of PIM-3 as a screening agent for identifying anti-type 2 diabetes mellitus drugs and for preparing a medicament for the treatment of insulin resistance or type 2 diabetes mellitus.
La présente invention concerne des molécules d'acide nucléique isolées et des cellules hôtes comportant lesdites molécules. Elle concerne en outre un polypeptide ayant une activité PIM-3 et possédant une séquence définie d'acides aminés, ainsi que l'utilisation de PIM-3 en tant qu'agent de criblage pour identifier des médicaments contre le diabète de type 2 et pour préparer un remède destiné à traiter la résistance à l'insuline ou diabète de type 2.
Korn Marcus
Mueller Guenter
Schneider Rudolf
Tschank Georg
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Pim-3 kinase as a target for type 2 diabetes mellitus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pim-3 kinase as a target for type 2 diabetes mellitus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pim-3 kinase as a target for type 2 diabetes mellitus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1517490